机译:与前列腺癌相关的MSMB基因启动子变异体调控MSMB / NCOA4融合转录本
Human Genetics Section, Basic Research Program, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, MD, 21702, USA;
Molecular Immunology Section, Basic Research Program, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, MD, 21702, USA;
Core Genotyping Facility, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD, 21702, USA;
Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA;
Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, 21702, USA;
Gene Regulation and Chromosome Biology Laboratory, Molecular Information Theory Group, Frederick, MD, 21702, USA;
Division of Cancer Epidemiology and Genetics, C;
机译:与前列腺癌相关的MSMB基因启动子变异调控MSMB / NCOA4融合转录本
机译:前列腺癌与MSMB,NCOA4基因变异和蛋白质表达之间关系的研究
机译:MSMB基因启动子中的功能多态性与前列腺癌风险和血清MSMB表达有关。
机译:“启动子阵列”研究鉴定了通过甲基化,拷贝数变化或人癌细胞中的转录因子结合直接调节的基因的群组
机译:核心结合因子转录调节前列腺特异性抗原基因,是前列腺癌细胞增殖所必需的
机译:启动子在与前列腺癌相关的基因msmB变体调节msmB / NCOa4融合转录
机译:10q11癌症风险位点的分析涉及MSMB和NCOA4在人类前列腺癌发生中的作用。
机译:前列腺肿瘤中ERG表达水平反映雄激素受体(aR)的功能状态,作为ERG与aR调节基因启动子融合的后果